New drug trial targets rare and aggressive blood cancers
Disease control
Recruiting now
This is the first study in humans to test a new drug called DR-01 for adults with rare and aggressive blood cancers, including large granular lymphocytic leukemia and several types of cytotoxic lymphomas. The main goals are to find a safe dose and see if the drug can shrink tumor…
Phase: PHASE1, PHASE2 • Sponsor: Dren Bio • Aim: Disease control
Last updated Apr 06, 2026 14:05 UTC